These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 12885911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N, Deacon PM, Lichty B, Mossman KL, Ashkar AA.
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [Abstract] [Full Text] [Related]

  • 3. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract.
    Gallichan WS, Woolstencroft RN, Guarasci T, McCluskie MJ, Davis HL, Rosenthal KL.
    J Immunol; 2001 Mar 01; 166(5):3451-7. PubMed ID: 11207303
    [Abstract] [Full Text] [Related]

  • 4. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA.
    Ashkar AA, Yao XD, Gill N, Sajic D, Patrick AJ, Rosenthal KL.
    J Infect Dis; 2004 Nov 15; 190(10):1841-9. PubMed ID: 15499542
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection.
    Harandi AM, Eriksson K, Holmgren J.
    J Virol; 2003 Jan 15; 77(2):953-62. PubMed ID: 12502811
    [Abstract] [Full Text] [Related]

  • 8. Treatment of intravaginal HSV-2 infection in mice: a comparison of CpG oligodeoxynucleotides and resiquimod (R-848).
    McCluskie MJ, Cartier JL, Patrick AJ, Sajic D, Weeratna RD, Rosenthal KL, Davis HL.
    Antiviral Res; 2006 Feb 15; 69(2):77-85. PubMed ID: 16377001
    [Abstract] [Full Text] [Related]

  • 9. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
    Bagri P, Anipindi VC, Nguyen PV, Vitali D, Stämpfli MR, Kaushic C.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28956763
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
    Tengvall S, Harandi AM.
    J Reprod Immunol; 2008 Jun 01; 78(1):49-57. PubMed ID: 17945349
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection.
    Gill N, Davies EJ, Ashkar AA.
    Am J Reprod Immunol; 2008 Jan 01; 59(1):35-43. PubMed ID: 18154594
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
    Jiang JQ, Patrick A, Moss RB, Rosenthal KL.
    J Virol; 2005 Jan 01; 79(1):393-400. PubMed ID: 15596832
    [Abstract] [Full Text] [Related]

  • 17. A crucial role for plasmacytoid dendritic cells in antiviral protection by CpG ODN-based vaginal microbicide.
    Shen H, Iwasaki A.
    J Clin Invest; 2006 Aug 01; 116(8):2237-43. PubMed ID: 16878177
    [Abstract] [Full Text] [Related]

  • 18. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice.
    Tengvall S, Josefsson A, Holmgren J, Harandi AM.
    J Reprod Immunol; 2005 Dec 01; 68(1-2):53-69. PubMed ID: 16229896
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.